Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-039070

Chief Scientific Officer sold 6,000 shares at $10.28 ($61,663)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Monahan Joseph · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-20 Sale : show line 1 in the form 10b5-1 −6,000 $10.28 $61,663 141,724 D
Open-market sales · 6,000 sh · avg $10.28 · $61,663
Loading xslF345X04/doc4.xml…